Objectives. Existing evidence indicates that late presentation of glaucoma (i.e. advanced visual field loss) is an important risk factor for subsequent blindness. This study was designed to identify the risk factors for first presenting to an NHS ophthalmologist with advanced glaucomatous visual field loss by comparing with a group who presented with early loss.;Design. Hospital-based case-control study with prospective identification of cases and controls.;Setting. Three Hospital Eye Departments in England.;Subjects. Consecutive patients newly diagnosed with glaucoma (n=220). Cases were those presenting with advanced glaucoma (n=110), controls were those with early glaucoma (n=110). Patients with a previous history of ocular hypertension o...
Purpose: To determine the proportion of blindness and investigate the relationships between risk fac...
Aim: To study the prevalence and risk factors of glaucoma in a health setting. Methods: The study w...
To determine the incidence of glaucomatous visual field loss (GVFL) two decades after the start of t...
Objectives. Existing evidence indicates that late presentation of glaucoma (i.e. advanced visual fie...
BACKGROUND: Glaucoma is the commonest cause of irreversible blindness worldwide. As it is typically ...
Aim: The aim was to identify the presenting symptoms and social risk factors for late presentation o...
BACKGROUND AND AIM: Undiagnosed glaucoma is an invisible but important public health issue. At least...
Context: POAG is a leading cause of irreversible blindness worldwide. Factors associated with the da...
OBJECTIVE: To explore the presentation behaviours and pathways to detection of adults who first pres...
Purpose: To investigate factors associated with bilateral glaucoma blindness, particularly factors a...
Purpose: To determine the 10-year incidence of glaucomatous visual field loss (GVFL) and to investig...
Purpose To evaluate frequency, conversion rate, and risk factors for blindness in glaucoma patients ...
Purpose: To determine the 10-year incidence of glaucomatous visual field loss (GVFL) and to investig...
Background: Until advanced, glaucoma is asymptomatic. For early diagnosis to occur, patients may nee...
To determine the incidence of glaucomatous visual field loss (GVFL) two decades after the start of t...
Purpose: To determine the proportion of blindness and investigate the relationships between risk fac...
Aim: To study the prevalence and risk factors of glaucoma in a health setting. Methods: The study w...
To determine the incidence of glaucomatous visual field loss (GVFL) two decades after the start of t...
Objectives. Existing evidence indicates that late presentation of glaucoma (i.e. advanced visual fie...
BACKGROUND: Glaucoma is the commonest cause of irreversible blindness worldwide. As it is typically ...
Aim: The aim was to identify the presenting symptoms and social risk factors for late presentation o...
BACKGROUND AND AIM: Undiagnosed glaucoma is an invisible but important public health issue. At least...
Context: POAG is a leading cause of irreversible blindness worldwide. Factors associated with the da...
OBJECTIVE: To explore the presentation behaviours and pathways to detection of adults who first pres...
Purpose: To investigate factors associated with bilateral glaucoma blindness, particularly factors a...
Purpose: To determine the 10-year incidence of glaucomatous visual field loss (GVFL) and to investig...
Purpose To evaluate frequency, conversion rate, and risk factors for blindness in glaucoma patients ...
Purpose: To determine the 10-year incidence of glaucomatous visual field loss (GVFL) and to investig...
Background: Until advanced, glaucoma is asymptomatic. For early diagnosis to occur, patients may nee...
To determine the incidence of glaucomatous visual field loss (GVFL) two decades after the start of t...
Purpose: To determine the proportion of blindness and investigate the relationships between risk fac...
Aim: To study the prevalence and risk factors of glaucoma in a health setting. Methods: The study w...
To determine the incidence of glaucomatous visual field loss (GVFL) two decades after the start of t...